HomeCompareAPDN vs GBDC

APDN vs GBDC: Dividend Comparison 2026

APDN yields 35.59% · GBDC yields 11.86%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GBDC wins by $20.67M in total portfolio value· pulled ahead in Year 5
10 years
APDN
APDN
● Live price
35.59%
Share price
$5.62
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$181.8K
Annual income
$27,846.09
Full APDN calculator →
GBDC
GBDC
● Live price
11.86%
Share price
$12.65
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.85M
Annual income
$16,450,733.83
Full GBDC calculator →

Portfolio growth — APDN vs GBDC

📍 GBDC pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAPDNGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, APDN + GBDC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
APDN pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

APDN
Annual income on $10K today (after 15% tax)
$3,024.91/yr
After 10yr DRIP, annual income (after tax)
$23,669.18/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.91/yr
After 10yr DRIP, annual income (after tax)
$13,983,123.76/yr
At 15% tax rate, GBDC beats the other by $13,959,454.58/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of APDN + GBDC for your $10,000?

APDN: 50%GBDC: 50%
100% GBDC50/50100% APDN
Portfolio after 10yr
$10.52M
Annual income
$8,239,289.96/yr
Blended yield
78.35%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

APDN
Analyst Ratings
3
Buy
1
Sell
Consensus: Buy
Price Target
$1.50
-73.3% upside vs current
Range: $1.50 — $1.50
Altman Z
-29.8
Piotroski
2/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.7% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

APDN buys
0
GBDC buys
0
No recent congressional trades found for APDN or GBDC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAPDNGBDC
Forward yield35.59%11.86%
Annual dividend / share$2.00$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.1%
Portfolio after 10y$181.8K$20.85M
Annual income after 10y$27,846.09$16,450,733.83
Total dividends collected$131.9K$20.43M
Payment frequencyquarterlyquarterly
SectorStockBDC
Analyst consensusBuyBuy
Analyst price target$1.50$14.00

Year-by-year: APDN vs GBDC ($10,000, DRIP)

YearAPDN PortfolioAPDN Income/yrGBDC PortfolioGBDC Income/yrGap
1$14,259$3,558.72$12,492$1,791.70+$1.8KAPDN
2$19,999$4,742.32$16,527$3,160.58+$3.5KAPDN
3$27,615$6,216.38$23,588$5,904.90+$4.0KAPDN
4$37,571$8,022.22$37,141$11,901.65+$430.00APDN
5← crossover$50,401$10,200.20$66,205$26,463.38$15.8KGBDC
6$66,717$12,788.31$137,452$66,612.65$70.7KGBDC
7$87,208$15,820.84$342,372$195,298.53$255.2KGBDC
8$112,640$19,327.04$1,053,292$686,954.33$940.7KGBDC
9$143,855$23,330.07$4,111,439$2,984,416.95$3.97MGBDC
10$181,771$27,846.09$20,849,974$16,450,733.83$20.67MGBDC

APDN vs GBDC: Complete Analysis 2026

APDNStock

Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection for various applications used to fortify brand protection efforts and strengthen supply chain security, as well as mark, track, and convict criminals; SigNify IF portable DNA readers and SigNify consumable reagent test kits that provide real-time authentication of molecular tags in the field; and CertainT, which indicates the use of tagging, testing, and tracking platforms and solutions enabling manufacturers, brands, and trade organizations to convey proof of their product claims. It also manufactures and sells COVID-19 PCR-based molecular diagnostic test kit under the LineaTM COVID-19 Assay Kit trademark; and COVID-19 diagnostic test kit to prevent virus spread within a community, school, or workplace under the safeCircle trademark. In addition, the company provides preclinical contract research and manufacturing services for the nucleic acid-based therapeutic markets; and contract research services to RNA based drug and biologic customers for preclinical studies. Further, it develops an invasive circulating tumor cell capture and identification technology that uses a patented functional assay to capture live invasive circulating tumor cell and associated lymphocytes. The company operates in the United States, Europe, Asia, and internationally. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.

Full APDN Calculator →

GBDCBDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this APDN vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

APDN vs SCHDAPDN vs JEPIAPDN vs OAPDN vs KOAPDN vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.